-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PVlvnW6gRJZu6dHHxfpjjnZan6s1e25twUQfGW1s75FqDmLrFcTDf8hW3w+/RQ+m R6s86ZIfe49L6C3Cevbbqw== 0000902561-02-000266.txt : 20020521 0000902561-02-000266.hdr.sgml : 20020521 20020521170233 ACCESSION NUMBER: 0000902561-02-000266 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020521 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DOV PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001066833 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223374365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78237 FILM NUMBER: 02659091 BUSINESS ADDRESS: STREET 1: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 2019680980 MAIL ADDRESS: STREET 1: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ CENTRAL INDEX KEY: 0001045520 STANDARD INDUSTRIAL CLASSIFICATION: COMMERCIAL BANKS, NEC [6029] IRS NUMBER: 00000 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PO BOX 770, SUITE 4440 STREET 2: BCE PLACE, 181 BAY STREET CITY: TORONTO ONTARIO STATE: A6 BUSINESS PHONE: 2128563612 MAIL ADDRESS: STREET 1: COMMERCE CT CITY: TORONTO ONTARIO STATE: A6 SC 13G 1 sc13g.txt ------------------------------ OMB APPROVAL ------------------------------ OMB Number 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response ..... 14.90 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DOV Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 259858108 ------------------------------------- (CUSIP Number) April 25, 2002 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages CUSIP No. 259858108 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1. Name of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Canadian Imperial Bank of Commerce ("CIBC") - -------------------------------------------------------------------------------- 2. Check the Appropriate Box If a Member of a Group (See Instructions) (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization CIBC is a bank organized under the Bank Act of Canada. - -------------------------------------------------------------------------------- 5. Sole Voting Power NUMBER OF 1,902,570 SHARES _________________________________________________________________ BENEFICIALLY 6. Shared Voting Power OWNED BY -0- EACH _________________________________________________________________ REPORTING 7. Sole Dispositive Power PERSON 1,902,570 WITH: _________________________________________________________________ 8. Shared Dispositive Power -0- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,902,570 - -------------------------------------------------------------------------------- 10. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [_] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (11) 12.7% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) OO - -------------------------------------------------------------------------------- CUSIP No. 259858108 13G Page 3 of 5 Pages - -------------------------------------------------------------------------------- Item 1(a). Name of Issuer: DOV Pharmaceuticals, Inc. (DOVP) - -------------------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: Continental Plaza 433 Hackensack Avenue Hackensack, New Jersey 07601 - -------------------------------------------------------------------------------- Item 2(a). Name of Person Filing: Canadian Imperial Bank of Commerce ("CIBC") - -------------------------------------------------------------------------------- Item 2(b). Address of Principal Business Office, or if None, Residence: Commerce Court West, 199 Bay Street Toronto, Ontario M5L 1A2 Canada - -------------------------------------------------------------------------------- Item 2(c). Citizenship: CIBC is a bank organized under the Bank Act of Canada. - -------------------------------------------------------------------------------- Item 2(d). Title of Class of Securities: Common Stock - -------------------------------------------------------------------------------- Item 2(e). CUSIP Number: 259858108 - -------------------------------------------------------------------------------- Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [_] CUSIP No. 259858108 13G Page 4 of 5 Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 1,902,570 (b) Percent of class 12.7% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 1,902,570 (ii) Shared power to vote or to direct the vote -0- (iii) Sole power to dispose or to direct the disposition of 1,902,570 (iv) Shared power to dispose or to direct the disposition of -0-
- -------------------------------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. Not applicable - -------------------------------------------------------------------------------- Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable - -------------------------------------------------------------------------------- Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. CIBC World Markets Corp., an indirectly-owned subsidiary of CIBC, beneficially owns 1,902,570 shares of DOV Pharmaceuticals common stock. - -------------------------------------------------------------------------------- Item 8. Identification and Classification of Members of the Group. Not applicable. CUSIP No. 259858108 13G Page 5 of 5 Pages - -------------------------------------------------------------------------------- Item 9. Notice of Dissolution of Group. Not applicable. - -------------------------------------------------------------------------------- Item 10. Certifications. Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. May 21, 2002 --------------------------------------------- (Date) /s/ Antonio Molestina --------------------------------------------- (Signature) Antonio Molestina Senior Vice President, Deputy General Counsel Canadian Imperial Bank of Commerce --------------------------------------------- (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----